Sotera Health (NASDAQ:SHC) Shares Acquired by Handelsbanken Fonder AB

Handelsbanken Fonder AB increased its stake in Sotera Health (NASDAQ:SHC) by 16.1% during the 4th quarter, Holdings Channel.com reports. The fund owned 47,500 shares of the company’s stock after buying an additional 6,600 shares during the period. Handelsbanken Fonder AB’s holdings in Sotera Health were worth $650,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of the stock. State of New Jersey Common Pension Fund D boosted its position in shares of Sotera Health by 21.5% in the fourth quarter. State of New Jersey Common Pension Fund D now owns 154,237 shares of the company’s stock worth $2,110,000 after acquiring an additional 27,247 shares during the last quarter. Rhumbline Advisers lifted its position in Sotera Health by 3.8% during the fourth quarter. Rhumbline Advisers now owns 399,171 shares of the company’s stock valued at $5,461,000 after buying an additional 14,616 shares in the last quarter. Blue Trust Inc. lifted its position in Sotera Health by 504.0% during the fourth quarter. Blue Trust Inc. now owns 4,192 shares of the company’s stock valued at $57,000 after buying an additional 3,498 shares in the last quarter. New York State Teachers Retirement System lifted its position in Sotera Health by 8.7% during the fourth quarter. New York State Teachers Retirement System now owns 58,173 shares of the company’s stock valued at $796,000 after buying an additional 4,673 shares in the last quarter. Finally, Entropy Technologies LP acquired a new position in Sotera Health during the fourth quarter valued at approximately $229,000. 91.03% of the stock is owned by institutional investors and hedge funds.

Sotera Health Trading Up 1.5 %

NASDAQ SHC opened at $12.47 on Friday. The company’s fifty day simple moving average is $13.45 and its 200-day simple moving average is $14.51. Sotera Health has a 52 week low of $10.71 and a 52 week high of $17.08. The company has a current ratio of 2.88, a quick ratio of 2.61 and a debt-to-equity ratio of 4.91. The stock has a market cap of $3.53 billion, a P/E ratio of 49.88 and a beta of 1.91.

Analyst Upgrades and Downgrades

SHC has been the topic of a number of recent research reports. Royal Bank of Canada reaffirmed an “outperform” rating and set a $17.00 price target on shares of Sotera Health in a research report on Thursday, November 21st. The Goldman Sachs Group initiated coverage on shares of Sotera Health in a research report on Friday, December 6th. They set a “neutral” rating and a $14.00 price target on the stock. Citigroup lifted their price target on shares of Sotera Health from $18.00 to $20.00 and gave the company a “buy” rating in a research report on Wednesday, November 6th. Finally, Barclays reduced their price target on shares of Sotera Health from $17.00 to $16.00 and set an “overweight” rating on the stock in a research report on Friday. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat, Sotera Health presently has a consensus rating of “Moderate Buy” and an average target price of $15.92.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.